Review |
Corresponding author: Ehab Qasim Talib ( ehab.q.t@aliraqia.edu.iq ) © 2024 Ehab Qasim Talib, Ghada Ibrahim Taha, Dhuha Mahmood Ali, Sahar Hashim Al-Hindawi, Fadia Abd Almuhsin Al-Khayat, Israa Amer Hasan.
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Citation:
Talib EQ, Taha GI, Ali DM, Al-Hindawi SH, Al-Khayat FAA, Hasan IA (2024) Microbial boundaries in peri-implantitis: a review of pathogen-related advances. Folia Medica 66(6): 763-769. https://doi.org/10.3897/folmed.66.e136356
|
In the field of implantology, peri-implantitis is still a common complication of implant failure. Similar to periodontal disease, this kind of pathological condition is characterized by inflammation of the tissues surrounding dental implants or fillings. The sources of infection have been shown to be chronic periodontitis and poor maintenance of the communion. A thorough examination of the intricate components of peri-implantitis was sought in this review in order to identify common characteristics of the disease with regard to bacteria, biofilm formation, host immunological responses, diagnostic tools, and therapeutic treatments. The aim of this study was to provide a detailed overview of the different bacterial species associated with peri-implantitis, a clinical condition similar to periodontitis, characterized by a higher prevalence of staphylococci and enteric bacteria. The study underscores the importance of employing sophisticated diagnostic methods like cone beam computed tomography. It covers a range of therapeutic approaches including surgical and non-surgical techniques as well as strategies stressing host-modification and photodynamic treatment. The study was conducted using pertinent publications from scientific databases, including Scopus, Google Scholar, PubMed, and Web of Science. We searched these databases using the following terms: periodontitis, microbial, dental implants, peri-implantitis, and biofilm formation.
biofilm formation, implants, microbial, peri-implantitis, periodontitis
Dentists often worry about peri-implantitis, a disease that causes swelling and pain in the soft and hard tissues around tooth implants.[
The prevalence of peri-implantitis differs, with some studies demonstrating that it was 19.53% at the patient-level and 12.53% at the implant-level.[
Peri-implant diseases are broadly divided into two groups: peri-implant mucositis and peri-implantitis. The former is essentially the first stage of peri-implantitis. Mucositis is a lesion where the gingival around the implant is inflamed, but there is no associated bone loss.[
A salivary pellicle quickly attaches to oral surfaces after implant insertion. This adsorption mechanism helps first bacterial colonizers connect and serve as surface receptors for later colonizers.[
The inflammatory destruction of implant-supporting tissues caused by biofilm formation on the implant surface is what causes peri-implantitis, a serious dental implant complication.[
Biofilm formation on dental implants, in which groups of germs form around the implant, is the main cause of peri-implantitis.[
The immune system’s reaction to germs on the tooth implant is very important for how peri-implantitis progresses and how long it lasts. This happens because biofilm forms on the surface of the implant, which causes inflammation cells to destroy surrounding tissues.[
Peri-implantitis is mostly caused by the immune system’s reaction to germs on implants.[
It makes the immune system respond like it does to periodontal diseases, letting different types of cells like neutrophils, macrophages, T-cells, and B-cells into the sores.[
Peri-implantitis can be diagnosed in several methods, including clinical evaluations, imaging methods and microbial tests.[
New developments in photodynamic therapy and host-modulating drugs have changed the way peri-implantitis is treated, mixing non-surgical and surgery methods.[
For diabetic patients with multiple implants, doctors may use CBCT imaging and antimicrobial treatment. For more complicated cases, like serious peri-implantitis with significant bone loss[
The management of peri-implantitis involves the strategic use of antibiotics and antimicrobial agents, both systemically and locally.[
Systemic antibiotics have not consistently been shown to improve clinical outcomes in the surgical treatment of peri-implantitis. Most systematic reviews and studies show little to no significant long-term benefit from the adjunctive use of systemic antibiotics. However, some evidence suggests a temporary advantage in certain situations, such as cases involving modified surface implants.[
For decades, the use of systemic antibiotics before surgery in peri-implantitis sites (e.g., brushes, insertion devices, lifting devices) has been a contentious issue. While existing implant placement protocols recommend antibacterial prophylactic measures, further studies have shown that such treatment does not enhance implant survival in straightforward surgeries involving healthy individuals. The lack of high-quality data from randomized controlled trials (RCTs) and the wide variability in diagnostic criteria contribute to the ongoing debate regarding the effectiveness and necessity of systemic antibiotics in the treatment of peri-implantitis.[
The use of locally administered antibiotics significantly reduces peri-implantitis indicators like peri-implant probing depth and bleeding on probing compared to control groups.[
Along with mechanical cleaning and chemical washing, local antibiotics like minocycline nanoparticles and doxycycline gel are used to get the drugs to the spot where they are needed. Antibiotics are delivered to gaps around implants by tetracycline fibers, metronidazole gel fights anaerobic infections, and chlorhexidine chips kill germs. Even though they do not have big effects, local medicines can help treatment work better.[
Peri-implantitis progression is influenced by the host immune system, biofilm and bacterial presence. In order to treat this oral condition, early detection, preventative measures, and advanced therapies are essential. Advanced surgical techniques and host-modulating therapies show promise for treatment results.
All authors have read and approved of the final manuscript.
The authors declare that they hold no competing interests.
The authors have no funding to report.